We are live on ! Find out more
TVGN icon

Tevogen Bio Holdings
TVGN

51 hedge funds and large institutions have $1.68M invested in Tevogen Bio Holdings in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

0% more ownership

Funds ownership: 0.05% → 0.05% (+0%)

6% less funds holding

Funds holding: 54 → 51 (-3)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

56% less capital invested

Capital invested by funds: $3.78M → $1.68M (-$2.1M)

Holders
51
Holders Change
-3
Holders Change %
-5.56%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
23
Reduced
10
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$79.3K
2
Deutsche Bank
Deutsche Bank
Germany
+$68K
3
Morgan Stanley
Morgan Stanley
New York
+$64.3K
4
XT
XTX Topco
Cayman Islands
+$29K
5
HF
HRT Financial
New York
+$27.2K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$186K
2
Creative Planning
Creative Planning
Kansas
-$39.3K
3
CUAMC
China Universal Asset Management Company
China
-$27.1K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$12.3K
5
ProShare Advisors
ProShare Advisors
Maryland
-$9.51K
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$7K – – –
VF
27
Virtu Financial
New York
$7K +$3.56K +137 +47%
Mirae Asset Global ETFs Holdings
28
Mirae Asset Global ETFs Holdings
Hong Kong
$6.32K +$3.09K +119 +45%
Citadel Advisors
29
Citadel Advisors
Florida
$5.71K +$8.97K +345 New
Neuberger Berman Group
30
Neuberger Berman Group
New York
$4.76K +$7.49K +288 New
AHL
31
Abel Hall LLC
Louisiana
$4.49K +$208 +8 +3%
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$4.48K +$2.29K +88 +48%
AQR Capital Management
33
AQR Capital Management
Connecticut
$4.32K -$5.07K -195 -43%
IIM
34
INTECH Investment Management
Florida
$4.16K -$884 -34 -12%
Invesco
35
Invesco
Georgia
$3.92K -$3.3K -127 -35%
Prudential Financial
36
Prudential Financial
New Jersey
$3.81K +$5.98K +230 New
SG
37
StoneX Group
New York
$3.62K +$5.69K +219 New
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$2.3K – – –
Legal & General Group
39
Legal & General Group
United Kingdom
$1.04K – – –
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$851 +$494 +19 +59%
Russell Investments Group
41
Russell Investments Group
United Kingdom
$777 – – –
AIP
42
Ameritas Investment Partners
Nebraska
$710 – – –
GI
43
GAMMA Investing
California
$684 +$1.07K +41 New
SCM
44
Sterling Capital Management
North Carolina
$336 +$26 +1 +5%
Citigroup
45
Citigroup
New York
$308 -$1.92K -74 -80%
Zurich Cantonal Bank
46
Zurich Cantonal Bank
Switzerland
$227 -$3.67K -141 -91%
PA
47
Parallel Advisors
California
$13 – – –
SS
48
SBI Securities
Japan
$1 – – –
Creative Planning
49
Creative Planning
Kansas
– -$39.3K -1,001 Closed
CUAMC
50
China Universal Asset Management Company
China
– -$27.1K -690 Closed
1
2
3

TVGN Hedge Fund Activity: Q4 2025 in Review

51 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Tevogen Bio Holdings (TVGN) for Q4 2025, worth a combined $1.68M — down 56% from $3.78M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TVGN and 7 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 23 added.

The largest buyer was Goldman Sachs, adding an estimated $79.3K. The largest seller was BlackRock, cutting an estimated $186K.

  • 51 institutional investors held Tevogen Bio Holdings (TVGN) as of Q4 2025, down from 54 in Q3 2025.
  • Funds reported $1.68M of Tevogen Bio Holdings stock for Q4 2025, down 56% quarter-over-quarter.
  • 7 funds opened new Tevogen Bio Holdings positions in Q4 2025 and 10 closed out, a net change of -3 holders.
  • The largest Tevogen Bio Holdings buyer in Q4 2025 was Goldman Sachs, an estimated $79.3K added.
  • The largest Tevogen Bio Holdings seller in Q4 2025 was BlackRock, an estimated $186K sold.

Based on aggregated 13F filings for Q4 2025.